tiprankstipranks
Trending News
More News >
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market
Advertisement

Citius Pharmaceuticals (CTXR) Technical Analysis

Compare
1,730 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Citius Pharmaceuticals’s (CTXR) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Citius Pharmaceuticals is a Buy.
Citius Pharmaceuticals’s (CTXR) 20-Day exponential moving average is 1.44, while Citius Pharmaceuticals’s (CTXR) share price is $1.23, making it a Sell.
Citius Pharmaceuticals’s (CTXR) 50-Day exponential moving average is 1.39, while Citius Pharmaceuticals’s (CTXR) share price is $1.23, making it a Sell.

Citius Pharmaceuticals (CTXR) Pivot Points

Aug 09, 2025, 02:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.15
1.21
1.24
1.31
1.34
1.40
1.43
Fibonacci
1.21
1.25
1.27
1.31
1.34
1.36
1.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Pharmaceuticals (CTXR) Moving Averages

Aug 09, 2025, 02:13 PM
Period
Simple
Exponential
MA5
1.32Sell
1.33Sell
MA10
1.40Sell
1.39Sell
MA20
1.49Sell
1.44Sell
MA50
1.33Sell
1.39Sell
MA100
1.17Buy
1.78Sell
MA200
2.71Sell
3.96Sell
Citius Pharmaceuticals’s (CTXR) 10-Day exponential moving average is 1.39, while Citius Pharmaceuticals’s (CTXR) share price is $1.23, making it a Sell.
Citius Pharmaceuticals’s (CTXR) 100-Day exponential moving average is 1.78, while Citius Pharmaceuticals’s (CTXR) share price is $1.23, making it a Sell.
Citius Pharmaceuticals’s (CTXR) stock price is $1.23 and Citius Pharmaceuticals’s (CTXR) 50-day simple moving average is 1.33, creating a Sell signal.
Citius Pharmaceuticals’s (CTXR) stock price is $1.23 and Citius Pharmaceuticals’s (CTXR) 100-day simple moving average is 1.17, creating a Buy signal.
Citius Pharmaceuticals’s (CTXR) stock price is $1.23 and Citius Pharmaceuticals’s (CTXR) 200-day simple moving average is 2.71, creating a Sell signal.

Citius Pharmaceuticals (CTXR) Technical Indicators

Aug 09, 2025, 02:13 PM
Name
Value
Implied Action
RSI (14)
43.16
Neutral
STOCH (9,6)
10.19
Buy
STOCHRSI (14)
10.14
Buy
MACD (12,26)
-0.03
Buy
ADX (14)
24.80
Neutral
Williams %R
-93.48
Buy
CCI (14)
-115.79
Buy
ATR (14)
0.16
-
Ultimate Oscillator
35.17
Neutral
ROC
-15.69
Sell
Citius Pharmaceuticals’s (CTXR) Relative Strength Index (RSI) is 43.16, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Trend Strength Indicator (ADX) is 24.80, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Commodity Channel Index (CCI) is -115.79, creating a Buy signal.
Citius Pharmaceuticals’s (CTXR) Price Rate of Change (ROC) is -15.69, creating a Sell signal.

FAQ

Is CTXR a Buy, Hold, or Sell?
Based on CTXR’s technical indicators, CTXR is a Sell.
    What is CTXR’s RSI (14)?
    CTXR’s RSI (14) is 43.16, which suggests CTXR is a Neutral.
      What is CTXR’s MACD?
      CTXR’s MACD is -0.03, which suggests CTXR is a Buy.
        What is CTXR’s 5-day moving average?
        CTXR’s 5-day moving average is 1.32, which suggests CTXR is a Sell.
          What is CTXR’s 20-day moving average?
          CTXR 20-day moving average is 1.49, which suggests CTXR is a Sell.
            What is CTXR’s 50-day moving average?
            CTXR’s 50-day moving average is 1.33, which suggests CTXR is a Sell.
              What is CTXR’s 200-day moving average?
              CTXR’s 200-day moving average is 2.71, which suggests CTXR is a Sell.
                What is CTXR’s Williams % R (14)?
                CTXR’s Williams % R (14) is -93.48, which suggests CTXR is a Buy.
                  What is CTXR’s CCI (14)?
                  CTXR’s CCI (14) is -115.79, which suggests CTXR is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis